{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:07:55Z","timestamp":1791299275553,"version":"4.1.0"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Cidofovir (CDV) is a broad-spectrum antiviral agent that has been approved for clinical use in the treatment of cytomegalovirus retinitis. It has also been used off label to treat a variety of other viral infections, including those caused by orf and molluscum contagiosum poxviruses. Because it is a dCMP analog, CDV is thought to act by inhibiting viral DNA polymerases. However, the details of the inhibitory mechanism are not well established and nothing is known about the mechanism by which the drug inhibits poxvirus DNA polymerases. To address this concern, we have studied the effect of the active intracellular metabolite of CDV, CDV diphosphate (CDVpp), on reactions catalyzed by vaccinia virus DNA polymerase. Using different primer-template pairs and purified vaccinia virus polymerase, we observed that CDV is incorporated into the growing DNA strand opposite template G's but the enzyme exhibits a lower catalytic efficiency compared with dCTP. CDV-terminated primers are also good substrates for the next deoxynucleoside monophosphate addition step, but these CDV + 1 reaction products are poor substrates for further rounds of synthesis. We also noted that although CDV can be excised from the primer 3\u2032 terminus by the 3\u2032-to-5\u2032 proofreading exonuclease activity of vaccinia virus polymerase, DNAs bearing CDV as the penultimate 3\u2032 residue are completely resistant to exonuclease attack. These results show that vaccinia virus DNA polymerase can use CDVpp as a dCTP analog, albeit one that slows the rate of primer extension. By inhibiting the activity of the proofreading exonuclease, the misincorporation of CDV could also promote error-prone DNA synthesis during poxvirus replication.<\/jats:p>","DOI":"10.1128\/aac.49.8.3153-3162.2005","type":"journal-article","created":{"date-parts":[[2005,7,27]],"date-time":"2005-07-27T06:52:45Z","timestamp":1122447165000},"page":"3153-3162","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":152,"title":["Mechanism of Inhibition of Vaccinia Virus DNA Polymerase by Cidofovir Diphosphate"],"prefix":"10.1128","volume":"49","author":[{"given":"Wendy C.","family":"Magee","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, The University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Y.","family":"Hostetler","sequence":"additional","affiliation":[{"name":"San Diego VA Healthcare System, School of Medicine, University of California, San Diego, La Jolla, California 92093-0676"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, The University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(02)00196-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/315190"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2003.11.015"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90600-9"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(03)00110-4"},{"key":"e_1_3_2_7_2","first-page":"1502","volume":"50","year":"1996","unstructured":"Cihlar, T., and M. S. Chen. 1996. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Mol. Pharmacol.50:1502-1510.","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90670-R"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000150563","volume":"40","year":"1997","unstructured":"De Clercq, E. 1997. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections. Intervirology40:295-303.","journal-title":"Intervirology"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/323464a0"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.11.3659"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1084"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.22.2127"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"29512","DOI":"10.1074\/jbc.273.45.29512","volume":"273","year":"1998","unstructured":"Hendricks, S. P., and C. K. Mathews. 1998. Allosteric regulation of vaccinia virus ribonucleotide reductase, analyzed by simultaneous monitoring of its four activities. J. Biol. Chem.273:29512-29518.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_15_2","first-page":"197","volume":"41","year":"1992","unstructured":"Ho, H. T., K. L. Woods, J. J. Bronson, H. De Boeck, J. C. Martin, and M. J. Hitchcock. 1992. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol.41:197-202.","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_16_2","first-page":"A66","volume":"53","year":"2002","unstructured":"Huggins, J. W., R. O. Baker, J. R. Beadle, and K. Y. Hostetler. 2002. Orally active ether lipid prodrugs of cidofovir for the treatment of smallpox. Antiviral Res.53:A66.","journal-title":"Antiviral Res."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1721"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.991-995.2002"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.24.12298-12307.2001"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200404000-00003"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/prep.1994.1059"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890440061010"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.2.404-412.2004"},{"key":"e_1_3_2_24_2","unstructured":"Sambrook J. E. F. Fritsch and T. Maniatis. 1989. Molecular cloning: a laboratory manual 2nd ed. Cold Spring Harbor Laboratory Press Cold Spring Harbor N.Y."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1329-1335.2002"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.2.869-879.1991"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb760"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(02)00195-X"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0686"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.594"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(96)00100-1"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6822(02)00089-2"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.8.3153-3162.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.8.3153-3162.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T14:00:20Z","timestamp":1645452020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.8.3153-3162.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1128\/AAC.49.8.3153-3162.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.8.3153-3162.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"2005-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-05-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}